Status:
UNKNOWN
Clinical Application of Laparo-endoscopic Single-site Surgery and Natural Orifice Transluminal Endoscopic in Gynecology
Lead Sponsor:
Peking Union Medical College Hospital
Collaborating Sponsors:
Chinese Medical Doctor Association
Chinese Obstetricians and Gynecologists Association
Conditions:
Cervical Cancer, Endometrial Cancer，Endometrial Lesion & Adnexal Lesion，Ectopic Pregnancy & Infertility，Pelvic Obstructive Disorder & Genital Tract Deformity
Eligibility:
FEMALE
18+ years
Brief Summary
The GLESS registry is a prospective multi-center observational registry. Data from the time of patient admission, operation, discharge, and follow-up will be collected for this registry. Eight gynecol...
Detailed Description
Founding of the group. In June 2016 with the support of the Chinese Medical Doctor's Association and Chinese OBGYN Association, the not-for-profit GLESS (including Notes) Working Group was founded. Th...
Eligibility Criteria
Inclusion
- \- Adults over 18 years of age, that have the conditions eligibility with severity meeting within the surgical indications of the 2017 Chinese expert consensus on GLESS. Eligibility will be confirmed by the gynecological surgeon who are treating at each location. Patients are recruited after admission and prior to the operation.
Exclusion
- Acute infection stage, preoperative deep venous thrombosis or hypercoagulability, fasting blood sugar \> 11.1 mmol/L, blood pressure \> 160/100 mmHg, liver and kidney dysfunction, mental illness and other surgical contraindications;
- Refuse to sign informed consent.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2022
Estimated Enrollment :
9000 Patients enrolled
Trial Details
Trial ID
NCT04096872
Start Date
November 1 2017
End Date
October 31 2022
Last Update
September 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gless-Notes
Beijing, Beijing Municipality, China, 100000